February 13, 2014 / 1:43 PM / in 4 years

MARKET PULSE-Time Warner, Angie's List, SunPower, Whole Foods

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures fell on Thursday. Dow Jones industrial average futures were down 0.76 percent at 15,822, S&P 500 futures were down 0.80 percent at 1,802.6 and Nasdaq 100 futures were down 0.66 percent at 3,600.5.

** COMCAST CORP, Wednesday close $55.24, -2.14 pct premarket

** TIME WARNER CABLE INC, Wednesday close $135.31, +9.48 pct premarket

** CHARTER COMMUNICATIONS INC Wednesday close $137.57, -8.77 pct premarket

Comcast Corp said on Thursday that it would buy Time Warner Cable for $45.2 billion in an all-stock deal that combines the two largest U.S. cable operators. The friendly takeover comes as a surprise after months of public pursuit of Time Warner by smaller rival Charter Communications.

** CISCO SYSTEMS INC, Wednesday close $22.85, -3.41 pct premarket

The network gear maker forecast on Wednesday a 6-8 percent revenue slide this quarter, underlining its struggle to rekindle demand in emerging markets like China, even as hardware spending sags globally.

** ANGIE’S LIST INC, $17.1, -19.65 pct premarket

Brokerage Raymond James cut its rating on the company’s stock to “market perform” from “strong buy,” while at least five other brokerages cut their price targets on Angie’s stock, following its fourth-quarter results on Wednesday.

The company, which operates a website that allows the public to review local businesses, forecast lower-than-expected revenue for the first quarter and said it expected marketing expenses to rise.

** GENERAC HOLDINGS INC, Wednesday close $49.89, +6.84 pct premarket

The generator maker reported a better-than-expected fourth-quarter profit, as its acquisitions of Ottomotores, Tower Light and Baldor generators drove up the sales of its commercial and industrial products.

** WHOLE FOODS MARKET INC, Wednesday close $55.46, -6.96 pct premarket

The largest U.S. organic and natural food retailer, on Wednesday, reported first-quarter results that missed the average analyst estimate and stunned investors by cutting its 2014 sales forecast for the second time in three months.

At least 9 brokerages cut their price targets on the company’s stock.

** ION GEOPHYSICAL CORP, $3.15, +26.98 pct premarket

The seismic data processing company reported fourth-quarter revenue way ahead of the average analyst estimate, helped by data library sales that more than doubled year-on-year, rising particularly in areas offshore East and West Africa, East and West India, and the Gulf of Mexico.

** B&G FOODS INC, $30.69, -3.84 pct premarket

The private-label food manufacturer, on Wednesday, reported a fourth-quarter profit that missed the average analyst estimate, hurt by a lower gross margin due to a net price decrease, a sales mix shift to lower margin products, and a rise in distribution costs.

** BURGER KING WORLDWIDE INC, Wednesday close $25.48, +3.81 pct premarket

The company, known for its Whopper hamburgers, reported a better-than-expected quarterly profit as new products, including the Big King sandwich and Satisfries french fries, drew customers in North America.

** PEPSICO INC, Wednesday close $81.49

The maker of Pepsi-Cola, Quaker Oats and Tropicana juice reported a better-than-expected 5 percent rise in quarterly profit and said it would return about $2.3 billion more to shareholders in 2014 in the form of share buybacks and dividend.

** DISCOVERY COMMUNICATIONS INC, Wednesday close $82.86

The company reported a 28 percent rise in quarterly revenue, helped by growth in its U.S. and international networks.

** AGNICO-EAGLE MINES LTD, Wednesday close $32.88, -3.83 pct premarket

The Canadian miner slashed its quarterly dividend to 8 cents per share from 22 cents, saying the reduction reflects current market conditions as gold is trading about $100 per ounce lower than the company’s realized price in 2013.

** SUNPOWER CORP, Wednesday close $31.62, -3.83 pct premarket

The U.S. solar company on Wednesday reported a fourth-quarter profit that soared past Wall Street estimates on strong solar demand in the U.S. utility and residential markets, but its 2014 outlook disappointed as investors had hoped for more from the fast-growing company.

** CBS CORP Wednesday close $61.85, +3.96 pct premarket

The media company on Wednesday reported a better-than-expected profit, announced an accelerated share buyback plan and raised its projection for revenue from pay television operators.

** HIMAX TECHNOLOGIES INC, $13.87, -0.14 pct premarket

The chipmaker reported fourth-quarter revenue ahead of the average analyst estimate, helped mostly by better-than-expected sales in smartphone and tablet applications for the Chinese and Korean markets.

** NVIDIA CORP Wednesday close $16.83, +3.68 pct premarket

The graphics chipmaker, on Wednesday, posted better-than-expected fourth-quarter revenue, fueled by its PC gaming components, even as it grapples with an expansion beyond computers and into mobile devices. The company also said it has halted plans to build a flashy new campus.

** CENOVUS ENERGY INC, Wednesday close $18.57

The Canadian oil and gas producer’s fourth-quarter operating profit fell short of analysts’ estimates as production at its Foster Creek oil sands project in northern Alberta dropped 11 percent.

** RETROPHIN INC, Wednesday close $10.68, +23.57 pct after market

The drugmaker said it would buy privately held Manchester Pharmaceuticals, a specialty pharmaceutical company that focuses on treatments for rare diseases, for $62.5 million.

Manchester markets two drugs that are approved by the U.S. Food and Drug Administration - Chenodal, for use in patients suffering from gallstones, and Vecamyl, for managing hypertension and uncomplicated cases of malignant hypertension.

** JOHNSON & JOHNSON Wednesday close $92.42

** PHARMACYCLICS INC Wednesday close $137

U.S. health regulators approved on Wednesday the two companies’ cancer drug, Imbruvica, to treat chronic lymphocytic leukemia, a slowly progressing form of blood cancer.

** ITRON INC, Wednesday close $39.19, -21.79 pct premarket

The power meter maker’s fourth-quarter revenue missed the average analyst estimate due to the unfavorable impact of changes in foreign currency exchange rates.

At least three brokerages cut their ratings on the Itron’s stock.

** PERCEPTRON INC, Wednesday close $14.36, -9.54 pct premarket

The maker of non-contact measurement and inspection products to the automotive and manufacturing industries reported a second-quarter loss, as engineering, research and development costs rose while revenue declined.

** THE MEDICINES CO Wednesday close $33.1, -13.29 pct premarket

An independent advisory panel to the U.S. Food and Drug Administration said the drugmaker’s blood clot preventer should not be approved due to a lack of data to prove its efficacy.

** FIDELITY NATIONAL FINANCIAL INC, Wednesday close $31.68, -4.51 pct after market

The title insurer’s net earnings and revenue fell as it earned less premiums due to declining refinance order volumes.

** NEWPORT CORP, Wednesday close $18.41, +3.92 pct after market

The optical instruments and hardware supplier reported better-than-expected results on Wednesday, helped mostly by new design wins and increased activity levels with customers in the microelectronics end market.

Brokerage B Riley and Co raised its price target on the company’s stock To $25.50 from $22.

** PIONEER ENERGY SERVICES, Wednesday close $9.1

The oilfield services provider reported a fourth-quarter loss compared with a profit a year earlier, mainly due to higher expenses.

Compiled by Garima Goel in Bangalore; Editing by Simon Jennings

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below